donating plasma on glp 1 Tirzepatide and Donation: Eligibility and Safety Guidelines Can You Donate Blood Plasma

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved a new indication for Wegovy (semaglutide) to reduce the risk of overweight and obese adults suffering serious heart problems or strokes.

Explore top LinkedIn economics content from experienced professionals.

For example, semaglutide and empagliflozin showed no significant difference in 3-point MACE (HR 1.05

Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data

Every ingredient and every batch of final product is independently tested for purity and potency

Key highlights: Once-daily oral administration Up to 11.8% weight loss over 36 weeks Focus on broader cardiometabolic health outcomes Advancement into Phase III development As obesity remains one of the most significant global health challenges, innovation in oral GLP-1 therapies could help improve accessibility and patient adherence while expanding treatment options beyond injectable therapies